Peapack-Gladstone Financial Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.77M | Buy |
2,837
+15
| +0.5% | +$10.2K | 0.02% | 354 |
|
|
2026
Q1 | $2.18M | Sell |
2,822
-9
| -0.3% | -$6.89K | 0.03% | 326 |
|
|
2025
Q4 | $2.19M | Sell |
2,831
-41
| -1% | -$27.8K | 0.03% | 333 |
|
|
2025
Q3 | $1.61M | Sell |
2,872
-145
| -5% | -$82K | 0.02% | 361 |
|
|
2025
Q2 | $1.58M | Buy |
3,017
+48
| +2% | +$26.8K | 0.02% | 352 |
|
|
2025
Q1 | $1.88M | Buy |
2,969
+130
| +5% | +$89.4K | 0.03% | 336 |
|
|
2024
Q4 | $2.02M | Buy |
2,839
+591
| +26% | +$496K | 0.03% | 325 |
|
|
2024
Q3 | $2.36M | Sell |
2,248
-20
| -0.9% | -$22.3K | 0.03% | 315 |
|
|
2024
Q2 | $2.38M | Sell |
2,268
-60
| -3% | -$58.2K | 0.04% | 304 |
|
|
2024
Q1 | $2.24M | Hold |
2,328
| – | – | 0.04% | 308 |
|
|
2023
Q4 | $2.04M | Sell |
2,328
-11
| -0.5% | -$9.06K | 0.03% | 317 |
|
|
2023
Q3 | $1.93M | Sell |
2,339
-10
| -0.4% | -$7.86K | 0.04% | 308 |
|
|
2023
Q2 | $1.69M | Buy |
2,349
+20
| +0.9% | +$15.4K | 0.03% | 320 |
|
|
2023
Q1 | $1.91M | Buy |
2,329
+22
| +1% | +$16.6K | 0.04% | 306 |
|
|
2022
Q4 | $1.66M | Buy |
2,307
+27
| +1% | +$19.9K | 0.03% | 318 |
|
|
2022
Q3 | $1.57M | Buy |
2,280
+160
| +8% | +$101K | 0.03% | 317 |
|
|
2022
Q2 | $1.25M | Sell |
2,120
-109
| -5% | -$70.9K | 0.03% | 328 |
|
|
2022
Q1 | $1.56M | Sell |
2,229
-12
| -0.5% | -$7.59K | 0.03% | 317 |
|
|
2021
Q4 | $1.42M | Buy |
2,241
+112
| +5% | +$68.9K | 0.03% | 331 |
|
|
2021
Q3 | $1.29M | Buy |
2,129
+60
| +3% | +$37.2K | 0.03% | 329 |
|
|
2021
Q2 | $1.16M | Sell |
2,069
-20
| -1% | -$10.1K | 0.03% | 319 |
|
|
2021
Q1 | $989K | Buy |
2,089
+611
| +41% | +$297K | 0.03% | 320 |
|
|
2020
Q4 | $714K | Sell |
1,478
-38
| -3% | -$20.5K | 0.02% | 277 |
|
|
2020
Q3 | $848K | Buy |
1,516
+142
| +10% | +$86.1K | 0.03% | 239 |
|
|
2020
Q2 | $857K | Sell |
1,374
-24
| -2% | -$13.6K | 0.03% | 234 |
|
|
2020
Q1 | $683K | Buy |
1,398
+106
| +8% | +$43.7K | 0.03% | 240 |
|
|
2019
Q4 | $485K | Buy |
1,292
+158
| +14% | +$53.2K | 0.02% | 258 |
|
|
2019
Q3 | $315K | Sell |
1,134
-35
| -3% | -$10.4K | 0.01% | 301 |
|
|
2019
Q2 | $366K | Sell |
1,169
-54
| -4% | -$18K | 0.02% | 282 |
|
|
2019
Q1 | $502K | Buy |
1,223
+90
| +8% | +$37.1K | 0.02% | 243 |
|
|
2018
Q4 | $423K | Buy |
1,133
+26
| +2% | +$9.52K | 0.02% | 246 |
|
|
2018
Q3 | $447K | Buy |
1,107
+6
| +0.5% | +$2.28K | 0.02% | 247 |
|
|
2018
Q2 | $380K | Sell |
1,101
-7
| -0.6% | -$2.19K | 0.02% | 259 |
|
|
2018
Q1 | $382K | Buy |
1,108
+96
| +9% | +$33.4K | 0.02% | 262 |
|
|
2017
Q4 | $380K | Buy |
1,012
+22
| +2% | +$8.91K | 0.02% | 258 |
|
|
2017
Q3 | $443K | Hold |
990
| – | – | 0.03% | 243 |
|
|
2017
Q2 | $486K | Sell |
990
-10
| -1% | -$4.38K | 0.03% | 225 |
|
|
2017
Q1 | $388K | Sell |
1,000
-140
| -12% | -$51.9K | 0.02% | 250 |
|
|
2016
Q4 | $418K | Buy |
1,140
+125
| +12% | +$47.5K | 0.03% | 226 |
|
|
2016
Q3 | $408K | Hold |
1,015
| – | – | 0.03% | 225 |
|
|
2016
Q2 | $354K | Hold |
1,015
| – | – | 0.02% | 241 |
|
|
2016
Q1 | $366K | Hold |
1,015
| – | – | 0.03% | 235 |
|
|
2015
Q4 | $551K | Hold |
1,015
| – | – | 0.04% | 205 |
|
|
2015
Q3 | $472K | Hold |
1,015
| – | – | 0.04% | 215 |
|
|
2015
Q2 | $518K | Hold |
1,015
| – | – | 0.04% | 205 |
|
|
2015
Q1 | $458K | Hold |
1,015
| – | – | 0.03% | 221 |
|
|
2014
Q4 | $416K | Hold |
1,015
| – | – | 0.03% | 225 |
|
|
2014
Q3 | $366K | Hold |
1,015
| – | – | 0.03% | 225 |
|
|
2014
Q2 | $287K | Buy |
1,015
+15
| +2% | +$4.45K | 0.02% | 255 |
|
|
2014
Q1 | $300K | Hold |
1,000
| – | – | 0.02% | 244 |
|
|
2013
Q4 | $275K | Hold |
1,000
| – | – | 0.02% | 252 |
|
|
2013
Q3 | $313K | Hold |
1,000
| – | – | 0.03% | 231 |
|
|
2013
Q2 | $225K | Buy |
+1,000
| New | +$233K | 0.02% | 266 |
|
Other funds holding REGN
Peapack-Gladstone Financial Corp's REGN Position: Q2 2026 in Review
Peapack-Gladstone Financial Corp increased its Regeneron Pharmaceuticals (REGN) stake by 0.53% in Q2 2026, buying an estimated $10.2K and bringing the position to 2,837 shares worth $1.77M. The position accounts for 0.02% of the portfolio, ranked #354.
Peapack-Gladstone Financial Corp first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.38M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Peapack-Gladstone Financial Corp held 2,837 shares of Regeneron Pharmaceuticals worth $1.77M as of Q2 2026.
- Peapack-Gladstone Financial Corp bought 15 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $10.2K.
- Regeneron Pharmaceuticals made up 0.02% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #354 holding.
- Peapack-Gladstone Financial Corp first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Peapack-Gladstone Financial Corp's Regeneron Pharmaceuticals position peaked at $2.38M in Q2 2024.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.